Patellofemoral Osteoarthritis

1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
1
Engineered cartilage graftPhase 21 trial
Active Trials
NCT06576583Recruiting150Est. Jan 2030

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
Geistlich PharmaEngineered cartilage graft

Clinical Trials (1)

Total enrollment: 150 patients across 1 trials

NCT06576583Geistlich PharmaEngineered cartilage graft

Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.

Start: Jul 2025Est. completion: Jan 2030150 patients
Phase 2Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 150 patients
1 companies competing in this space